Sustained release morphine sulfate capsules in patients with pain related to gastrointestinal cancer

被引：0
作者：
Budai, E
机构：
[1] Semmelweis University of Medicine,1st Department of Surgery
来源：
CLINICAL DRUG INVESTIGATION | 1997年 / 14卷 / Suppl 1期
关键词：
Morphine; Adis International Limited; Pain Relief; Sustained Release; Drug Invest;
D O I：
10.2165/00044011-199700141-00011
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：59 / 61
页数：3
相关论文
共 50 条
  • [21] Food Effects on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules
    Johnson, Franklin
    Ciric, Sabrina
    Boudriau, Sophie
    Swearingen, Dennis
    Stauffer, Joseph
    ADVANCES IN THERAPY, 2010, 27 (11) : 846 - 858
  • [22] Effects of Alcohol on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules
    Johnson, Franklin K.
    Ciric, Sabrina
    Boudfiau, Sophie
    Kisicki, James
    Stauffer, Joseph
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (05) : 747 - 756
  • [23] Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain
    Clark, AJ
    Ahmedzai, SH
    Allan, LG
    Camacho, F
    Horbay, GLA
    Richarz, U
    Simpson, K
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1419 - 1428
  • [24] Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain
    Tassain, V
    Attal, N
    Fletcher, D
    Brasseur, L
    Dégieux, P
    Chauvin, M
    Bouhassira, D
    PAIN, 2003, 104 (1-2) : 389 - 400
  • [25] Long-Term Safety and Efficacy of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules, a Novel Formulation Containing Morphine and Sequestered Naltrexone, in Patients with Chronic, Moderate to Severe Pain
    Webster, Lynn R.
    Brewer, Randall
    Wang, Chao
    Sekora, Doreen
    Johnson, Franklin K.
    Morris, David
    Stauffer, Joseph
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 40 (05) : 734 - 746
  • [26] Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine-treatment for cancer pain
    Broomhead, A
    Kerr, R
    Tester, W
    OMeara, P
    Maccarrone, C
    Bowles, R
    Bus, B
    Hodsman, P
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 14 (02) : 63 - 73
  • [27] Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management
    Mercadante, Sebastiano
    Porzio, Giampiero
    Ferrera, Patrizia
    Fulfaro, Fabio
    Alelli, Federica
    Verna, Lucilla
    Villari, Patrizia
    Ficorella, Corrado
    Gebbia, Vittorio
    Riina, Salvatore
    Casuccio, Alessandra
    Mangione, Salvatore
    EUROPEAN JOURNAL OF PAIN, 2008, 12 (08) : 1040 - 1046
  • [28] The Relative Bioavailability of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules (EMBEDA®) and an Extended Release Morphine Sulfate Capsule Formulation (KADIAN®) in Healthy Adults Under Fasting Conditions
    Johnson, Franklin K.
    Ciric, Sabrina
    Boudriau, Sophie
    Kisicki, James C.
    Stauffer, Joseph
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (01) : 2 - 8
  • [29] Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules
    Nicholson, B
    Ross, E
    Weil, A
    Sasaki, J
    Sacks, G
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (03) : 539 - 550
  • [30] PHARMACOKINETICS AND EFFICACY OF RECTAL VERSUS ORAL SUSTAINED-RELEASE MORPHINE IN CANCER-PATIENTS
    WILKINSON, TJ
    ROBINSON, BA
    BEGG, EJ
    DUFFULL, SB
    RAVENSCROFT, PJ
    SCHNEIDER, JJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 (03) : 251 - 254
12345